Veeva Systems announced a collaboration with Amgen to accelerate innovation in clinical trials. A global biotechnology leader, Amgen will use the Veeva Clinical Platform to support and identify efficiencies across the clinical trial process, building on its commitment to accelerating the development of new medicines for patients with serious diseases.
“In collaboration with Veeva, we are leveraging advanced technologies to unlock new capabilities for our end-to-end study workflows, which should further strengthen our ability to deliver innovative treatments to patients quickly and at scale,” said Scott Skellenger , Senior Vice President and Chief Information Officer at Amgen.
Also Read: Tempus AI Acquires Paige to Advance AI in Precision Medicine
“We are excited to help Amgen further advance clinical development. The Veeva Clinical Platform will provide the foundation for standardized and connected processes that can accelerate the delivery of life-saving medicines to patients in need,” said Jim Reilly , President of Veeva Development Cloud.
Source: PRNewswire
